All Stories

It's curtain close for Spotlight: Gene editing biotech shutters

CRISPR-based Spotlight Therapeutics has shut down, former CEO Mary Haak-Frendscho, Ph.D., confirmed with Fierce Biotech.

Feb 19, 2025 - 22:37
 0
It's curtain close for Spotlight: Gene editing biotech shutters
CRISPR-based Spotlight Therapeutics has shut down, former CEO Mary Haak-Frendscho, Ph.D., confirmed with Fierce Biotech.
Read More

Tags:

Previous Article

How NIMBYs Derailed The First British Grand Prix

Next Article

The Best Margarita Recipes for Every Palate

Related Posts

‘I don't feel we lost momentum’: Takeda’s oncology execs sharpen focus after restructuring

‘I don't feel we lost momentum’: Takeda’s oncology exec...

Mar 13, 2025  0

Eli Lilly inks duo of deals, teaming with AdvanCell, OliX to push deeper into radiopharma, MASH

Eli Lilly inks duo of deals, teaming with AdvanCell, Ol...

Feb 10, 2025  0

Sanofi bounces midstage ILT2 asset back to Biond Biologics after $125M bet

Sanofi bounces midstage ILT2 asset back to Biond Biolog...

Mar 3, 2025  0